SCPS (Scopus BioPharma) Other Stockholders Equity: $-0.01 Mil (As of Jun. 2023)


What is Scopus BioPharma Other Stockholders Equity?

Scopus BioPharma SCPS Other Stockholders Equity is $-0.01 Mil as of Jun. 2023.

Scopus BioPharma's Other Stockholders Equity for the quarter that ended in Jun. 2023 was $-0.01 Mil.

Scopus BioPharma's quarterly Other Stockholders Equity increased from Dec. 2022 ($-0.03 Mil) to Mar. 2023 ($-0.03 Mil) and increased from Mar. 2023 ($-0.03 Mil) to Jun. 2023 ($-0.01 Mil).

Scopus BioPharma's annual Other Stockholders Equity increased from Dec. 2020 ($-1.50 Mil) to Dec. 2021 ($0.00 Mil) but then declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-0.03 Mil).

Scopus BioPharma Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Scopus BioPharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scopus BioPharma Other Stockholders Equity Chart

Scopus BioPharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
Get a 7-Day Free Trial -0.00 -0.00 -1.50 0.00 -0.03

Scopus BioPharma Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.03 -0.03 -0.01

Scopus BioPharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.01 Mil mean?
Scopus BioPharma (SCPS) has a Other Stockholders Equity of $-0.01 Mil as of Jun. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Scopus BioPharma and its competitors.
Is Scopus BioPharma's Other Stockholders Equity too high?
Scopus BioPharma's current Other Stockholders Equity is $-0.01 Mil.
How does Scopus BioPharma's Other Stockholders Equity compare to AMPE and DRMA?
Scopus BioPharma's Other Stockholders Equity of $-0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Scopus BioPharma and its competitors. Scopus BioPharma's current Other Stockholders Equity is $-0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scopus BioPharma stock overvalued right now?
Scopus BioPharma (SCPS) has a current Other Stockholders Equity of $-0.01 Mil. The current Other Stockholders Equity is $-0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Scopus BioPharma (SCPS), the current Other Stockholders Equity is $-0.01 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scopus BioPharma Business Description

Address 420 Lexington Avenue, Suite 300, New York, NY, USA, 10170
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.